Literature DB >> 30364251

Protection of tight junction between RPE cells with tissue factor targeting peptide.

Xiu-Lan Zou1, Guan-Feng Wang2, Dan-Dan Li3, Jing-Xia Chen1, Chun-Li Zhang1, Yong-Zhen Yu1, Wen-Jie Zhou1, Yu-Ping Zou1, Ben-Qiang Rao4.   

Abstract

AIM: To investigate the effect of tissue factor targeting peptide (TF-TP) on retinal pigment epithelium (RPE) cells tight junctions.
METHODS: Cell counting kit-8 (CCK-8) was used to measure the proliferation of ARPE-19 cells. Expression of tight junction, ZO-1 in ARPE-19 cells was measured by Western blot and immunofluorescent staining. Western blot was also used to detect the expression of tissue factor (TF). CEC Transmigration Assay was used to measure the migration of ARPE-19 cells. The transport of fluorescent markers [fluorescein isothiocyanate dextrans of 4, 10, 20 (FD4, FD10, FD20)] and the transepithelial electrical resistance (TEER) were used to measure in ARPE-19 cell.
RESULTS: CCK-8 assay showed that 5 µmol/L TF-TP can inhibit ARPE-19 cells abnormally proliferation stimulated by lipopolysaccharide (LPS; P<0.05). LPS increased the transport of fluorescent markers (FD4, FD10, FD20) and decreased TEER levels in ARPE-19 cells, respectively, which were prevented by 5 µmol/L TF-TP pretreatment (P<0.05). Furthermore, LPS significantly up-regulated the expression of TF and downregulated the expression of ZO-1 (P<0.05) in ARPE-19 cell which was inhibited by the TF-TP (P<0.05). In addition, TF-TP inhibited the abnormal migration induced by LPS in ARPE-19 cell (P<0.05).
CONCLUSION: Our findings suggest that TF-TP suppressed proliferation and migration of ARPE-19 cells induced by LPS, and maintained the RPE tight junctions through inhibition of TF expression and increased expression of ZO-1.

Entities:  

Keywords:  ZO-1; lipopolysaccharide; retinal pigment epithelium; tight junction; tissue factor targeting peptide

Year:  2018        PMID: 30364251      PMCID: PMC6192970          DOI: 10.18240/ijo.2018.10.04

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  31 in total

1.  The role of Bcl-xL in mouse RPE cell survival.

Authors:  Sarah Medearis; Ian C Han; Jessica K Huang; Ping Yang; Glenn J Jaffe
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-17       Impact factor: 4.799

2.  Tissue factor with age-related macular degeneration.

Authors:  Guan-Feng Wang; Xiu-Lan Zou
Journal:  Int J Ophthalmol       Date:  2012-10-18       Impact factor: 1.779

Review 3.  Role of tissue factor in thrombosis. Coagulation-inflammation-thrombosis circuit.

Authors:  Arthur J Chu
Journal:  Front Biosci       Date:  2006-01-01

Review 4.  Initiation of coagulation by tissue factor.

Authors:  R R Bach
Journal:  CRC Crit Rev Biochem       Date:  1988

Review 5.  Tissue factor as a link between inflammation and coagulation.

Authors:  Marco Witkowski; Ulf Landmesser; Ursula Rauch
Journal:  Trends Cardiovasc Med       Date:  2015-12-17       Impact factor: 6.677

6.  Targeting of junctional adhesion molecule-C inhibits experimental choroidal neovascularization.

Authors:  Xu Hou; Dan Hu; Yu-sheng Wang; Zhong-shu Tang; Fan Zhang; Triantafyllos Chavakis; Yang Li; Xuri Li
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-03-21       Impact factor: 4.799

7.  Targeting tissue factor for immunotherapy of choroidal neovascularization by intravitreal delivery of factor VII-Fc chimeric antibody.

Authors:  Tongalp H Tezel; Ewa Bodek; Kenan Sönmez; Sankar Kaliappan; Henry J Kaplan; Zhiwei Hu; Alan Garen
Journal:  Ocul Immunol Inflamm       Date:  2007 Jan-Feb       Impact factor: 3.070

8.  Evidence for enhanced tissue factor expression in age-related macular degeneration.

Authors:  Youngeun Cho; Xiaoguang Cao; DeFen Shen; Jingsheng Tuo; Leonard M Parver; Frederick R Rickles; Chi-Chao Chan
Journal:  Lab Invest       Date:  2010-11-01       Impact factor: 5.662

9.  Endogenous VEGF is required for visual function: evidence for a survival role on müller cells and photoreceptors.

Authors:  Magali Saint-Geniez; Arindel S R Maharaj; Tony E Walshe; Budd A Tucker; Eiichi Sekiyama; Tomoki Kurihara; Diane C Darland; Michael J Young; Patricia A D'Amore
Journal:  PLoS One       Date:  2008-11-03       Impact factor: 3.240

10.  Effects of Yeast and Bacterial Commensals and Pathogens of the Female Genital Tract on the Transepithelial Electrical Resistance of HeLa Cells.

Authors:  Vassiliki Tsata; Aristea Velegraki; Anastasios Ioannidis; Cornelia Poulopoulou; Pantelis Bagos; Maria Magana; Stylianos Chatzipanagiotou
Journal:  Open Microbiol J       Date:  2016-04-30
View more
  5 in total

Review 1.  Retinal pigment epithelium polarity in health and blinding diseases.

Authors:  Paulo S Caceres; Enrique Rodriguez-Boulan
Journal:  Curr Opin Cell Biol       Date:  2019-09-10       Impact factor: 8.382

2.  Toxic effects of A2E in human ARPE-19 cells were prevented by resveratrol: a potential nutritional bioactive for age-related macular degeneration treatment.

Authors:  Agustina Alaimo; Mariana Carolina Di Santo; Ana Paula Domínguez Rubio; Gabriela Chaufan; Guadalupe García Liñares; Oscar Edgardo Pérez
Journal:  Arch Toxicol       Date:  2019-12-02       Impact factor: 5.153

3.  A Comprehensive Proteomic and Phosphoproteomic Analysis of Retinal Pigment Epithelium Reveals Multiple Pathway Alterations in Response to the Inflammatory Stimuli.

Authors:  Juha Song; Dohyun Han; Heonyi Lee; Da Jung Kim; Joo-Youn Cho; Jae-Hak Park; Seung Hyeok Seok
Journal:  Int J Mol Sci       Date:  2020-04-25       Impact factor: 5.923

4.  Silenced SNHG1 Inhibited Epithelial-Mesenchymal Transition and Inflammatory Response of ARPE-19 Cells Induced by High Glucose.

Authors:  Jing Yang; Kun Yang; Xuxia Meng; Penghui Liu; Yudong Fu; Yibo Wang
Journal:  J Inflamm Res       Date:  2021-04-20

5.  Caffeine Protects Against Retinal Inflammation.

Authors:  Federica Conti; Francesca Lazzara; Giovanni Luca Romano; Chiara Bianca Maria Platania; Filippo Drago; Claudio Bucolo
Journal:  Front Pharmacol       Date:  2022-01-06       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.